Editorial
 THE BRAND NAME ISSUE   
 Thursday, February 13, 2020 
 Some of the pharmaceutical companies in the country have been indulging in the unethical practice of marketing their formulations in the old registered brand names even after changing the active pharmaceutical ingredients of these drug formulations. 
  Past Editorial...  
TODAY'S NEWS
12:00  [IST]Scynexis completes patient enrollment in phase 3 VANISH-306 study of oral ibrexafungerp to treat vulvovaginal candidiasis
11:00  [IST]Shimmer Research announces OWEAR actively soliciting algorithms & datasets for wearable and connected health technologies
10:00  [IST]Genetic profile may predict chance of type 2 diabetes among women with gestational diabetes
09:00  [IST]Granules India eyes 25% CAGR growth by FY 2022
more news >>
TOP NEWS
08:00  [IST]Kerala MP seeks PM’s intervention for domestic production of TB drugs bedaquiline & delamanid through compulsory license
08:00  [IST]Draft DMR Bill outlines strict provisions for false health claims in electronic media ads
08:00  [IST]Marketing cos raise concern about sharing onus of drug quality along with manufacturers in new D&C Rules
08:00  [IST]New MDMCs set up in Uttarahand, Karnataka & Gujarat to report adverse events related to medical device
08:00  [IST]Indian pharma keen on WHO policy brief for medicine traceability to stall warning letters from regulators & remain unscathed
08:00  [IST]Health ministry issues notification to make marketers liable for drug quality along with manufacturers
more news >>
YESTERDAY'S NEWS
18:00  [IST]US FDA grants fast track status to Soligenix's RiVax for prevention of ricin intoxication
17:00  [IST]NIH study shows remdesivir prevents MERS coronavirus disease in monkeys
16:00  [IST]US FDA grants priority review status to Deciphera Pharma’s Ripretinib to treat gastrointestinal stromal tumors
18:00  [IST]HCG invests Rs.20 crore to install Siemens Biograph Vision 600 digital PET CT scanner for high precision diagnosis in cancer
17:45  [IST]Lupin launches generic Moxeza in US market
17:30  [IST]Ryan Group collaborates with Fortis Healthcare for mental health initiatives
more news >>
INTERVIEW  
Med-tech ramps up accurate diagnosis with AI and algorithms
120287Ayelet_Interview Dr Ayelet Akselrod-Ballin, director of AI, Zebra Medical Vision
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the DoP's recent amendment to Para 32 of DPCO to provide 5-year price control exemption to patented innovative & rare diseases drugs a right move to increase accessibility ?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Chemspex_reg-2020.gif
CPhI_Japan_150x60_2020.jpg
Gulfood_2020
CPhI_China_150x60_CP
BioAsia_2020
pharma_Proj_150x60
Gandhi_auto_2019_Panel
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |